CountryFocus Healthcare Regulatory and Reimbursement Landscape

CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape – China Is Released
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China Summary GlobalData, the
industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape – China.
The report is an essential source of information on and analysis of the healthcare, regulatory and
reimbursement landscape in China. It identifies the key trends in the countrys healthcare market and
provides insights into its demographic, regulatory, and reimbursement landscape and healthcare
infrastructure. The population of China in 2014 was approximately 1.37 billion, having grown at a
Compound Annual Growth Rate (CAGR) of 0.5% from 2008. The countrys increasingly elderly population
and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the
pharmaceutical industry, which was estimated to be worth $106.5 billion in 2008 and is projected to
reach $1,637.3 billion by 2020, at a CAGR of 25.6%. Approximately 95% of China s population has
healthcare coverage. Improvements in drug safety and quality; a shorter drug registration timeline; the
elimination of price caps by the government; a more transparent system for the approval of drugs and
medical instruments; and an IPR regime are driving innovation in the pharmaceutical sector. These
changes encourage foreign Multinational Companies (MNC) to invest in China. The Chinese medical
device market is the second largest in Asia, valued at $27.7 billion in 2014 and projected to grow at a
CAGR of 10.6% to an estimated $50.8 billion in 2020.
These growth trends can be primarily attributed to the following causes - - Sedentary lifestyles leading
to a high chronic disease burden. - The accessibility of healthcare professionals in the remote areas of
the county. Scope The report provides information on the healthcare, regulatory, and reimbursement
landscape in China, and includes - - An overview of the pharmaceutical and medical device markets,
comprising market size, segmentation, and key drivers and barriers - Profiles and SWOT analyses of the
major players in the pharmaceutical market: GlaxoSmithKline, Pfizer, AstraZeneca, Harbin
Pharmaceutical Group and Tianjin Tasly Pharmaceutical; and profiles and SWOT analyses of the major
players in the medical device market: Siemens Healthcare, GE Healthcare, Philips, Medtronic and F.
Hoffman La Roche - Insightful review of the reimbursement and regulatory landscape, with analysis
covering details of the countrys healthcare reimbursement process, regulatory agencies and the
approval processes for new drugs and medical devices - Detailed analysis of the political and economic
environment, covering economic indicators, demographics, healthcare infrastructure and healthcare
expenditure - An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy This report will enhance your decision-making capability by allowing you to - - Develop
business strategies by understanding the trends shaping and driving Chinas healthcare market - Drive
revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical
market segments, and companies likely to affect Chinas healthcare market in the future - Formulate
effective sales and marketing strategies by understanding the competitive landscape and analyzing the
performance of various competitors - Organize your sales and marketing efforts by identifying the
market categories and segments that present the best opportunities for consolidation, investment, and
strategic partnerships - Identify, understand, and capitalize on the opportunities and challenges in
Chinas healthcare market
1

Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=197217/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china
To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=197217/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china
Table of Contents
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 11
1.2 List of Figures 15
2 Introduction 19
2.1 GlobalData Report Guidance 19
3 Overview of Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Exports and Imports 24
3.1.3 Supply Channels 25
3.1.4 Market Segments 26
3.1.5 Overview of Top Five Disease Areas 27
3.1.6 Major Players 30
3.2 Medical Device Market 63
3.2.1 Market Overview 63
3.2.2 Overview of Top Five Segments 65
3.2.3 Diagnostic Market 81
3.2.4 Major Players 84
3.3 Market Drivers and Barriers 112
3.3.1 Drivers 112
3.3.2 Barriers 114
4 Market Access 115
4.1 Overview of the Healthcare System 115
4.2 Reimbursement and Payer Landscape 115
4.2.1 Reimbursement Process 115
4.2.2 Overview of Insurance Providers 117
4.2.3 Patient Share in Healthcare Spending 117
4.2.4 Prescription Drug Price Trend 119
4.2.5 Pricing Policies 120
4.3 Regulatory Landscape 120
4.3.1 Overview of Regulatory Agencies 120
4.3.2 Market Authorization Procedure for Pharmaceutical Products 122
4.3.3 Market Authorization Procedure for Medical Devices 125
4.3.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 129
4.3.5 Licensing Process for Pharmaceutical Exports and Imports 131
4.3.6 Intellectual Property Rights 132
4.3.7 Clinical Trial Regulations 134
4.3.8 Pharmaceutical Advertising Regulations 135
4.3.9 Pharmacy Regulations 136
2

4.3.10 Labeling and Packaging Regulations 137
5 Country Analysis 139
5.1 Political Environment 139
5.1.1 Political Structure 139
5.1.2 Analysis of the Current Political Environment 140
5.1.3 Healthcare Policy Initiatives 141
5.2 Economic Landscape 143
5.3 Economic Indicators 148
5.3.1 Gross Domestic Product 148
5.3.2 Gross National Income 151
5.3.3 Inflation 152
5.3.4 Currency Exchange Rate 155
5.3.5 Foreign Direct Investment 156
5.3.6 Foreign Exchange Reserves 157
5.3.7 Trade Balance 159
5.3.8 General Government Structural Balance 162
5.3.9 General Government Gross Debt 163
5.3.10 Major Industries 164
5.4 Demographics 166
5.4.1 Population 166
5.4.2 Education and Literacy Rate 181
5.4.3 Employment 183
5.4.4 Disease Burden 184
5.5 Healthcare Infrastructure 188
5.5.1 Hospitals 188
5.5.2 Healthcare Facilities 189
5.5.3 Healthcare Parameters 191
5.5.4 Environmental Health 193
5.5.5 Healthcare Personnel 197
5.6 Healthcare Expenditure 198
5.6.1 Overview 198
5.6.2 Public and Private Sector Share 200
5.7 Trade Associations 201
5.7.1 China Chamber of Commerce for Import and Export of Medicines and Health Products 201
5.7.2 China Healthcare Association 201
5.7.3 Shanghai Medical Instrument Trade Association 201
5.7.4 Chinese Hospital Association 201
5.7.5 China Pharmaceutical Industry Association 202
5.8 Trade Fairs 202
6 Opportunities and Challenges 203
6.1 Opportunities 203
6.2 Challenges 204
7 Appendix 206
7.1 Abbreviations 206
7.2 Bibliography 209
7.3 Research Methodology 219
7.3.1 Coverage 219
3

7.3.2 Secondary Research 220
7.3.3 Forecasts 220
7.3.4 Expert Panel 220
7.4 Disclaimer 221
Read More http://www.idatainsights.com/reports-landing-page.php?id=197217/countryfocushealthcare-regulatory-and-reimbursement-landscape-china
About Us:
iData Insights which operates under Precision Research and Consulting Private Limited is a leading
market research information aggregator and marketing research consulting firm. We conduct both
primary and secondary research. Our work does not end with research it is also involved in distributing
reports for different companies . We provide actionable recommendations and provide our expertise for
business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and
discovery, and then be their guide in the implementation of changes that will make a difference to their
bottom line.
ContactUs:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com
About iData Insights
We work around the clock until our clients are completely satisfied with their promised results. It is our
mission to provide timely services coupled with acute client care to create a long-lasting relationship
with you. We deliver on our promise to provide results that are essential to the success of your
company. We believe that by doing so, we will earn the trust of our clients for future projects
4